Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
EUR 70,38
Anzahl: 15 verfügbar
In den WarenkorbPAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.
Sprache: Englisch
Verlag: American Psychiatric Publishing, 2007
ISBN 10: 0890422990 ISBN 13: 9780890422991
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 88,21
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Sprache: Englisch
Verlag: American Psychiatric Association Publishing, 2007
ISBN 10: 0890422990 ISBN 13: 9780890422991
Anbieter: moluna, Greven, Deutschland
EUR 75,78
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. This deeply informative compendium distills the work done from 2002 to late 2005 and concludes with recommendations for developing research activities that will inform DSM-V and future editions of the manual. As such, it will prove invaluable for clinicians.
Sprache: Englisch
Verlag: American Psychiatric Publishing Jun 2007, 2007
ISBN 10: 0890422990 ISBN 13: 9780890422991
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Neuware - Inviting the help of colleagues worldwide, the concise Diagnostic Issues in Substance Use Disorders is part of the new series Advancing the Research Agenda for DSM-V. Its 19 chapters by an international group of experts are designed to stimulate questions that will help guide research related to the development of the next editions of the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) and the International Classification of Diseases (ICD-11), with the goal of ensuring that the major substance use diagnoses represent the same condition in both references. They cover 10 major issues in three main sections: - Overarching issues relevant for the development of international diagnostic systems-statistical modeling techniques and whether DSM-V should use categorical and/or dimensional diagnostic approaches; methods review, emphasizing new hybrid techniques for developing and testing diagnostic concepts; the need for separate clinical and research-oriented diagnostic criteria, incorporating both categorical and dimensional attributes; neurobiological changes characterizing substance dependence; the importance of cultural attributes in developing definitions of substance use disorders; and the history of the development of diagnostic systems and how to optimize the 'crosswalk' between DSM and ICD.- Research questions more specific to the substance use disorders section of DSM--comorbidity between substance use disorders and other psychiatric conditions, the relatively unique clinical course of substance-induced mental disorders and appropriate treatment approaches; the precision of the criteria and threshold for a diagnosis and how to improve them; the subtypes of substance use disorder, including how they have been derived and the extent to which they relate to neurobiological processes; the seemingly high prevalence of alcohol dependence in young people; suggested research questions to evaluate the application of diagnostic criteria to adolescents; and the specific psychoactive substances cannabis and nicotine.- Whether substance use disorders should be included in a broader section termed 'addictive disorders'--impulse-control disorders (especially pathological gambling and the advantages and disadvantages of adding it to the current substance use disorders section), identifying research opportunities regarding their assessment and neurocognitive and physiological bases, discussing the specifics of the research agenda and how it might be implemented, and presenting questions generated by the research agenda developmental process.